Benign Prostatic Hyperplasia
- Benign prostatic hyperplasia (BPH) is overgrowth of the central gland — specifically the transition zone, the doughnut of tissue hugging the urethra.
- It's benign. The "problem" is plumbing: an enlarging gland squeezes the urethra and makes peeing a chore.
- On imaging the giveaways are an enlarged prostate with rounded, often heterogeneous nodules in the transition zone, frequently bulging up into the bladder.
- Two numbers people care about: how big the gland is (volume) and how much pee is left behind after voiding (post-void residual).
- The whole reason a radiologist sweats over BPH is that it can mimic — and hide — prostate cancer.
Imagine a garden hose running through the middle of a slowly inflating water balloon. The balloon doesn't hurt the hose, exactly — it just hugs it tighter and tighter until the stream out the end goes from "firehose" to "sad dribble." That balloon is the prostate. The hose is the urethra. That, in one slightly damp metaphor, is benign prostatic hyperplasia.
What's actually growing
The prostate isn't one uniform blob. It has zones, and BPH is picky about which one it bothers. It targets the transition zone — the ring of tissue that wraps directly around the urethra, like the dough around the hole of a doughnut. (Hold onto the doughnut. We'll need it later.)
As men age, this transition zone tends to enlarge, forming nodules. "Hyperplasia" just means more cells than there used to be — not abnormal cells, just an enthusiastic crowd of normal ones. Crucially, this is not cancer and doesn't turn into cancer. It's the architectural equivalent of your closet slowly filling up: nothing in there is dangerous, there's just too much of it, and now the door won't shut.
The peripheral zone — the back outer rim of the gland — is where most prostate cancer lives. BPH is a transition-zone story. Keeping those two neighborhoods straight is half the battle in prostate imaging.
Why anyone cares: it's a plumbing problem
The symptoms are all about flow. As the transition zone swells, it pinches the urethra and pushes up against the bladder neck. The result is the classic constellation of lower urinary tract symptoms — weak stream, hesitancy ("ready when you are, bladder"), incomplete emptying, and getting up three times a night to negotiate with a reluctant faucet.
The bladder, being a muscle, fights back by working harder, and over time its wall thickens and can develop little out-pouchings. If the obstruction gets bad enough, urine backs up all the way to the kidneys — that's the genuinely worrying end of the spectrum, and the reason BPH isn't purely a quality-of-life nuisance.
What it looks like on imaging
BPH is often first noticed incidentally — on a CT or ultrasound ordered for something else entirely, the radiologist clocks a prostate that's frankly too big and bulging up into the bladder floor like a thumb pressing into a balloon.
On ultrasound (transabdominal, or transrectal for detail), the gland is enlarged and the central portion looks heterogeneous and nodular. On MRI, the appearance is the most distinctive: the transition zone fills with well-defined, rounded nodules of mixed signal — a look people describe as "organized chaos." Glandular nodules tend to be bright on T2; stromal nodules darker.
Two measurements carry the clinical weight:
| What's measured | Why it matters |
|---|---|
| Prostate volume | Sizes the gland (roughly length × width × height × 0.52). Bigger gland, generally more obstruction, and it guides treatment choice. |
| Post-void residual (PVR) | Ultrasound estimate of urine left in the bladder right after peeing. A large residual means the bladder isn't emptying — a sign the obstruction is winning. |
The trap: BPH versus cancer
Here's where the doughnut comes back to bite us. BPH nodules can be heterogeneous, can restrict diffusion, and can look angry enough to make you reach for the biopsy gun. But most of that drama lives in the transition zone, where BPH belongs — whereas the lesions you truly fear tend to sit in the peripheral zone.
A rounded, well-encapsulated transition-zone nodule is the friendly face of BPH. A lesion that's ill-defined, lentiform (lens-shaped), erases the normal boundary, or smudges into the capsule is the one that earns a worried second look. Don't let a busy, nodular transition zone lull you into ignoring the peripheral zone — and don't call every bright BPH nodule a tumor.
This is exactly the tension the scoring systems were built to manage, and it's why transition-zone lesions get graded with extra suspicion on dedicated prostate MRI — covered over in Prostate Cancer Staging (mpMRI).
How it gets fixed
Most men start with medications that relax the urethra or shrink the gland. When pills aren't enough, urologists offer procedures to physically core out or vaporize the obstructing tissue. Interventional radiology has a stake here too: prostate artery embolization starves the gland of blood supply so it shrinks, easing the squeeze without surgery.
If you remember one thing: BPH is a benign overgrowth of the transition zone that strangles the urethra. It won't become cancer — but a crowded, nodular gland is exactly the camouflage cancer loves, so the radiologist's job is to read the plumbing and keep one eye on the peripheral zone.